Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

8.73
-0.0300-0.34%
Post-market: 8.780.0500+0.57%19:30 EDT
Volume:1.41M
Turnover:12.37M
Market Cap:576.30M
PE:-2.32
High:9.03
Open:8.70
Low:8.62
Close:8.76
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:1.54
T/O Rate:2.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:8.03
PE(LYR):-2.32

Loading ...

Regenxbio to Join Baird, Morgan Stanley Healthcare Investor Conferences

Reuters
·
Sep 08

Top Premarket Gainers

MT Newswires Live
·
Aug 28

Regenxbio Climbs as New Director Buys Nearly $1 Million of Stock

Reuters
·
Aug 28

Regenxbio director buys $949.4K in common stock

TIPRANKS
·
Aug 28

Regenxbio Director Gregory Austin Ciongoli Acquires Common Shares Worth $952,001.59

Reuters
·
Aug 28

Regenxbio Director Gregory Austin Ciongoli Files Initial Beneficial Ownership Statement

Reuters
·
Aug 28

Regenxbio Inc. : H.c. Wainwright Cuts Target Price to $21 from $23

THOMSON REUTERS
·
Aug 25

Regenxbio Appoints Greg Ciongoli to Board of Directors

Reuters
·
Aug 25

Regenxbio Strengthens Board of Directors with Appointment of Greg Ciongoli

THOMSON REUTERS
·
Aug 25

Regenxbio Inc. : Clear Street Cuts Target Price to $32 from $45

THOMSON REUTERS
·
Aug 25

Regenxbio is Maintained at Outperform by Baird

Dow Jones
·
Aug 25

Regenxbio price target lowered to $32 from $45 at Clear Street

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Ansell (OtherANSLF)

TIPRANKS
·
Aug 25

Top Midday Decliners

MT Newswires Live
·
Aug 25

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

TIPRANKS
·
Aug 24

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Regenxbio Shares Down 25% Premarket After FDA Places Clinical Hold on Co's Gene Therapy for Hunter Syndrome

THOMSON REUTERS
·
Aug 24

Regenxbio reports FDA placed clinical hold on RGX-121

TIPRANKS
·
Aug 24

FDA Places Clinical Hold on Regenxbio RGX-121 Gene Therapy for Hunter Syndrome After Spine MRI Findings

Reuters
·
Aug 24

Regenxbio - Co and Ns Pharma Evaluating Additional Data for Rgx-121

THOMSON REUTERS
·
Aug 24